OBN Annual Awards: HaemO2 Shortlisted

OBN have announced the nominations for their prestigious Annual Awards. Presented on the Thursday 2 October 2014, in Oxford’s historic Ashmolean Museum, they will applaud the cream of UK bioscience, diagnostics and medtech companies. Eleven awards are up for grabs, and HaemO2 have been nominated for 'Best New Medtech Development Programme.'

http://www.haemo2.com/news.html

BIotrinity 2014

First presentation of Haemo2 progress at Biotrinity on 12 May in London to an external audience by Mike Lewis.

HaemO2 Website Launch

Introducing the new HaemO2 website, for information and developments in creating a blood substitute for the 21st Century.

MRC funding award

MRC Developmental Pathway Funding Scheme (£1.2 million) ““Engineering a new generation of blood substitutes”